Cerus Corporation, a leading biotechnology firm headquartered in the United States, has been at the forefront of blood safety and transfusion medicine since its founding in 1991. With a strong operational presence across North America and Europe, Cerus is dedicated to developing innovative solutions that enhance the safety of blood products. The company’s flagship product, the INTERCEPT Blood System, utilises advanced pathogen inactivation technology, setting it apart in the industry. This system significantly reduces the risk of transfusion-transmitted infections, making it a vital tool for healthcare providers. Cerus has achieved notable milestones, including regulatory approvals and partnerships that underscore its commitment to improving patient outcomes. As a pioneer in blood safety, Cerus Corporation continues to solidify its market position through ongoing research and development, ensuring the highest standards in transfusion practices.
How does Cerus Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cerus Corporation's score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cerus Corporation, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Cerus Corporation's climate commitments and initiatives remain unclear, and there is no inherited emissions data from a parent or related organization. The company may be in the early stages of developing its climate strategy or reporting framework. In the context of the industry, it is essential for companies like Cerus Corporation to establish clear emissions reduction targets and commitments to align with global climate goals and enhance sustainability practices.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cerus Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
